Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1104-1111

  Demirer, Taner ^a,b   Ayli, Meltem ^a   Dagli, Mehmet ^c   Haznedar, Rauf ^d   Genc, Yasemin ^b   Fen, Turgay ^c   Dincer, Suleyman ^a   Unal, Ekrem ^b   Gunel, Nazan ^d   Seyrek, Ertugrul ^e   Ustun, Tulay ^a   Ustael, Nilufer ^a   Yildiz, Mustafa ^a   Sertkaya, Durdu ^f   Ozet, Gulsum ^a   Muftuoglu, Osman ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ANKARA ONCOLOGY HOSPITAL   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Post transplant G CSF; Stem cell transplant

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CYCLOSPORIN; EPIRUBICIN; ETOPOSIDE; MELPHALAN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; GRANULOCYTE; HOSPITALIZATION; HUMAN; HUMAN CELL; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE MYELOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TESTIS CARCINOMA; THROMBOCYTE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PLATELET COUNT; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 18544387267     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03762.x     Document Type: Article

References (24)

1. Regimen related toxicity in patients undergoing bone marrow transplantation
2. Factors that influence collection and engraftment of autologous peripheral blood stem cells
3. G-CSF post-autologous progenitor cell transplantation: A randomized study of 5, 10, and 16 micrograms/kg/day
4. Delayed G-CSF after autologous progenitor cell transplantation: A prospective randomized trial
5. Hematologic recovery and survival of lymphoma patients after autologous stem cell transplantation: Comparison of bone marrow and peripheral blood progenitor cells
6. Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma
7. Clinical uses of growth factors
8. Peripheral blood stem cell mobilization for high-dose chemotherapy
9. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
10. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: A randomized study
11. Colony-stimulating factors in stem cell transplantation: Effect on quality of life
12. Impact of autologous bone marrow infusion on the hematopoietic recovery following high-dose cyclophosphamide, etoposide and cisplatin
13. Nonparametric estimation from incomplete observations
14. Granulocyte colony stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial
15. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit
16. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation
17. The administration of growth factors post-PBPC transplantation abrogates the dose-effect of CFU-GM on the rate of PMN recovery
18. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation
19. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
20. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor-cell transplantation
21. Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit
22. Use of growth factors following autologous hematopoietic stem cell transplantation
23. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
24. Phase I-II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma